Imaging of Kidney Cancer

Softcover Nachdruck of the original 1. Auflage 2006
ISBN: 978-3-662-50002-6
Verlag: Springer

Buch, Englisch, 439 Seiten, Previously published in hardcover, Format (B × H): 193 mm x 260 mm, Gewicht: 1177 g

Reihe: Diagnostic Imaging

This is one of the first books to deal specifically with diagnostic imaging of the entire spectrum of kidney cancers. Both new and conventional imaging modalities are fully considered. After an introductory chapter on the histopathological classification of kidney cancers, the advantages and disadvantages of the various imaging modalities used in the diagnosis and assessment of disease extension are documented. Subsequent chapters offer an exhaustive description of the radiological features of the different histological subtypes of kidney cancer, with radiological and histological illustrations and tables. The latest innovations in interventional and minimally invasive procedures are also well covered. The book benefits from carefully chosen and technically excellent images. Each of the 24 chapters is written by an internationally acclaimed expert, making this book the most current and complete treatment of the subject available. It should be of great interest to radiologists, oncologists, and urologists.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Guermazi, Ali

Weitere Mitwirkende

Baert, A.L.

Bosniak, M.A.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Radiologie, Bildgebende Verfahren
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Urologie, Andrologie, Venerologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Nuklearmedizin, PET, Radiotherapie

Inhaltsverzeichnis

Histopathological Classification.- Ultrasound and Doppler in Kidney Cancer.- CT in Kidney Cancer.- Magnetic Resonance Imaging in Kidney Cancer.- Angiography in Kidney Cancer.- PET and PET/CT in Kidney Cancer.- Renal Cell Carcinoma.- Transitional Cell Carcinoma.- Kidney Sarcomas.- Cystic Renal Masses.- Collecting Duct Carcinoma.- Renal Sinus Neoplasms.- Small Renal Neoplasms.- Unusual Kidney Cancers.- Hereditary Renal Cancer.- Extraosseous Metastases and Local Recurrence.- Imaging of Bone Metastases.- Renal Lymphoma.- Lymphoproliferative Neoplasms.- Pediatric Kidney Cancer.- Percutaneous Biopsy and Radiofrequency Ablation.- Transarterial Embolization.- Preoperative Navigation of Nephron-Sparing Surgery.- Laparoscopic Partial Nephrectomy.

Über Autor(innen)

Dr Guermazi is currently at Synarc Inc, a company specializing in clinical research involving radiology. As Scientific Director of Oncology Services, he is in charge of oncology studies, including clinical trials involving kidney cancer. Previously, he was a Visiting Associate Professor in the Department of Radiology at the University of California San Francisco, working with Pr. Harry K. Genant. Before his American experience, he was a radiologist at Saint-Louis Hospital in Paris for 12 years. Saint-Louis Hospital is one of the 2 or 3 most respected hospitals in the world for treatment of cancer. In his time there, Dr Guermazi worked with literally thousands of patients with cancer. His previous clinical experience and current research give Dr. Guermazi a depth of knowledge on the subject that makes him unusually well qualified to edit this volume. He has also edited a previous book in this series on the radiological aspects of hematological disorders, and has written numerous papers on the radiological aspects of many other diseases.

Co-authors include Elliot Fishman, Peter Mueller, Nancy Curry, Ronald Zagoria, Gary Israel, Lisa Lowe, and Christian Schiepers, all extremely well known and well respected physicians with established reputations as international leaders in the field of kidney cancer.